Get started
MarketMoversReport

Chembio Diagnostics Awarded $3.2 Million Contract

Long
MarketMoversReport  
NASDAQ:CEMI   None
Beyond Technical Analysis
0
0
beyondta
CEMI: Chembio Diagnostics, Inc.
2022-09-06 08:00:00 Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.